Safety of magnesium-lidocaine combination for severe head injury: the Turin lidomag pilot study.
Neuroprotection in the setting of severe head injury (SHI) remains an unsettled problem. We tested a combination of high-dose magnesium and low-dose lidocaine, infused over 3 days, in a pilot study to assess safety. This combination appears indicated to protect both gray and white matter from secondary injury following SHI. We studied 32 consecutive patients admitted to the emergency department of our hospital, a large tertiary referral center. No toxicity was observed. Mortality was lower than published statistics. These results open the stage to a controlled randomized study.